In an alopecia areata trial, a novel bifunctional therapy that blocks signaling of the interleukin-7 and TSLP pathways ...

Bempikibart demonstrated positive, durable responses among patients with severe to very severe alopecia areata, according to ...

A white hair patch, medically known as poliosis, refers to a localized area of hair that turns white or gray due to the ...

Discover a study where findings highlighted the effectiveness of low-dose oral minoxidil as an alternative to topical ...

Eli Lilly (NYSE:LLY) has recently unveiled significant advancements across its product line, including promising results from ...

Thirty-six weeks of once-daily, oral baricitinib was associated with greater hair regrowth on the scalp, eyebrows and ...

Panelists discuss how the introduction of Janus kinase (JAK) inhibitor therapies will likely change treatment algorithms for alopecia areata (AA), with insights on how payers should plan for coverage ...

Brittany Craiglow, MD, FAAD, analyzed the promising use of baricitinib for severe pediatric alopecia areata. She highlighted late-breaking data from the BRAVE-AA-PEDS study (NCT05723198), emphasizing ...

After suffering "occassional small patches" Zoe's alopecia returned in force in 2022 and she told The Guardian: "I had this monumental breakup and it really went. There’s a bit of you going: 'It’s ...

Late-breaking results from Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) found adolescent patients (ages 12 to ...

Hair loss is a widespread issue, often causing significant distress. While some embrace baldness as "the new sexy," many ...

Of the states that do provide coverage for JAK inhibitors used to treat patients with alopecia, researchers found that prior ...